Company Qingdao NovelBeam Technology Co.,Ltd.

Equities

688677

CNE100005410

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Qingdao NovelBeam Technology Co.,Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-03 EDT			5-day change	1st Jan Change
41.37 ^CNY	+0.17%		-3.25%	-22.28%

05-08	Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023.	CI
05-08	Qingdao NovelBeam Technology Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	CI

Qingdao NovelBeam Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of medical endoscopic equipment and optical products. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The Company distributes its products both in the domestic market and to overseas markets.

Number of employees: 797

CNY in Million	2022	Weight	2023	Weight	Delta
Medical Endoscope Equipment 71.2 %	335	70.4 %	335	71.2 %	-0.12%
Optical Products 20.7 %	110	23.1 %	97	20.7 %	-11.63%
Maintenance 7.7 %	31	6.4 %	36	7.7 %	+18.34%
Lease 0.4 %	1	0.1 %	2	0.4 %	+154.36%
Technical 0.1 %	0	0.0 %	0	0.1 %	+903.27%

CNY in Million	2022	Weight	2023	Weight	Delta
United States 60.9 %	303	63.6 %	286	60.9 %	-5.61%
China 30.4 %	112	23.4 %	143	30.4 %	+28.25%
Asia (excluding China) 7.8 %	56	11.8 %	37	7.8 %	-35.24%
Europe 0.7 %	4	0.8 %	3	0.7 %	-18.52%
South America 0.2 %	1	0.3 %	1	0.2 %	-9.99%

Managers	Title	Age	Since
Yao Zheng CEO	Chief Executive Officer	50	-
Fang Hua Wang DFI	Director of Finance/CFO	56	04-04-30
Jin Lan Zheng CHM	Chairman	42	07-02-28
An Min Zheng CHM	Chairman	59	-
Min Ma COO	Chief Operating Officer	52	-
Chang Ming Gu CTO	Chief Tech/Sci/R&D Officer	52	-
Huan Xue IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
An Min Zheng CHM	Chairman	59	-
Jun Cui BRD	Director/Board Member	60	19-12-27
Yong Xiang Jiang BRD	Director/Board Member	55	15-09-25
Chang Ming Gu CTO	Chief Tech/Sci/R&D Officer	52	-
Zhong Qiang Li BRD	Director/Board Member	54	-
Jie Gang Huang BRD	Director/Board Member	53	19-12-27
Zi Li Zhang BRD	Director/Board Member	59	19-12-27
Jin Lan Zheng CHM	Chairman	42	07-02-28
Xun Yi Wang BRD	Director/Board Member	47	15-09-25
Xin Liu BRD	Director/Board Member	29	21-09-23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	122,314,501	66,833,786 ( 54.64 %)	677,120 ( 0.5536 %)	54.64 %

Name	Equities	%	Valuation
Orient Securities Asset Management Co. Ltd. 7.577 %	5,697,613	7.577 %	35 M ¥
Da Cheng Fund Management Co., Ltd. 4.566 %	3,433,288	4.566 %	21 M ¥
New China Fund Management Co., Ltd. 4.041 %	3,038,689	4.041 %	19 M ¥
China Southern Asset Management Co., Ltd. 2.491 %	1,873,241	2.491 %	12 M ¥
ABC-CA Fund Management Co., Ltd. 1.936 %	1,455,871	1.936 %	9 M ¥
Truvalue Asset Management Co. Ltd. 1.555 %	1,169,341	1.555 %	7 M ¥
Cinda Fund Management Co. Ltd. 1.348 %	1,013,347	1.348 %	6 M ¥
Yinhua Fund Management Co., Ltd. 1.082 %	813,704	1.082 %	5 M ¥
JPMorgan Asset Management (China) Co Ltd. 0.9901 %	744,556	0.9901 %	5 M ¥
Aegon-Industrial Fund Management Co., Ltd. 0.9549 %	718,061	0.9549 %	4 M ¥

Name	Equities	%	Valuation
QINGDAO NOVELBEAM TECHNOLOGY CO.,LTD. 0.45%	336,548	0.45%	2,081,146 $

Qingdao NovelBeam Technology Co., Ltd.

100 Keyuanweisi Road Laoshan District

266100, Qingdao

http://www.novelbeam.com

address Qingdao NovelBeam Technology Co.,Ltd.(688677)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

41.37 CNY

Average target price

60.75 CNY

Spread / Average Target

+46.85%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
QINGDAO NOVELBEAM TECHNOLOGY CO.,LTD.	-22.28%	688M
THERMO FISHER SCIENTIFIC	+7.32%	217B
DANAHER CORPORATION	+13.83%	195B
INTUITIVE SURGICAL, INC.	+20.48%	144B
BOSTON SCIENTIFIC CORPORATION	+31.33%	112B
SIEMENS HEALTHINEERS AG	+3.57%	65.83B
EDWARDS LIFESCIENCES CORPORATION	+14.64%	52.67B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.72%	49.86B
AGILENT TECHNOLOGIES, INC.	-5.88%	38.18B
GE HEALTHCARE TECHNOLOGIES INC.	+0.25%	35.39B

Other Advanced Medical Equipment & Technology